Billionaire Profile
Ramesh Juneja
Global Rank
#1531

Image: Bollywood Hungama | CC BY 3.0 | via Wikimedia Commons

Ramesh Juneja

CEO, Pharmaceuticals
INDIA
Real-Time Net Worth
$2.75B
Estimated based on Pharmaceuticals stock value as of May 3, 2026
0% (24h)
Age
70
Source
Pharmaceuticals
Industry
Healthcare
Citizenship
INDIA

Biography

Ramesh Juneja is an Indian billionaire businessman best known as the co-founder and chairman of Mankind Pharma, a leading pharmaceutical company in India. His net worth is estimated at $2.9 billion as of 2024. Juneja's career began in 1974 as a medical representative. In 1995, he co-founded Mankind Pharma with his brother Rajeev Juneja, and the company grew to be the fourth-largest pharmaceutical company in India by domestic sales value by 2024..

Fact Checked
Verified by Editorial Team
Live Data
Updated 5/3/2026

Wealth Over Time

In-Depth Profile

Early Life and Career

Ramesh Juneja was born in Meerut, Uttar Pradesh, India, in 1955. He graduated in science and started his career in the pharmaceutical industry in 1974 as a Medical Representative at KeePharma Ltd.. In this role, he traveled extensively to meet doctors and promote pharmaceutical products. He worked for Lupin Limited for eight years, gaining insights into the pharmaceutical sector.

Rise to Success

In 1995, Ramesh Juneja, along with his brother Rajeev Juneja, co-founded Mankind Pharma. The company started with an initial investment of ₹50 lakhs. Mankind Pharma focused on providing affordable, quality medicines and quickly grew. Key milestones include the successful introduction of brands like Manforce, Prega News, and Unwanted 72. The company's 2023 IPO further solidified its position, with Mankind Pharma becoming the fourth-largest pharmaceutical company in India by domestic sales value in 2024.

Key Business Strategies

Ramesh Juneja's strategies included emphasizing affordable generic medicines to reach a wide audience. He focused on brand recognition and created well-known brands like Manforce. He has also expanded through strategic acquisitions. The company has invested in research and development. Ramesh Juneja has also expanded the company's reach and product portfolio by making astute acquisitions. The company also made popular brands of condoms and pregnancy test kits.

Philanthropy

Ramesh Juneja has also been involved in philanthropic activities through Mankind Pharma's CSR initiatives. The company has contributed to scholarships for underprivileged students and supported educational infrastructure. The company has also contributed to COVID-19 relief efforts.

Career Milestones

1974

Medical Representative

Began his career at KeePharma Ltd.

1975

First-line manager

Joined Lupin Limited.

1995

Co-founded Mankind Pharma

Founded Mankind Pharma with his brother Rajeev Juneja.

2023

IPO of Mankind Pharma

Mankind Pharma went public.

2023

Entrepreneur of the Year

Awarded the Entrepreneur of the Year at the Economic Times Awards for Corporate Excellence.

2025

Deal Maker Award

Honored with the Deal Maker Award at the BT MindRush event.

Philanthropy & Social Impact

Healthcare

COVID-19 Relief

$6.1 million

Committed INR 51 crore to support COVID-19 relief, including aid for frontline workers and medical infrastructure.

Healthcare and Education

JC Juneja Foundation

Undisclosed

Funded medical treatments for 40,000 beneficiaries in FY 2023-24, focusing on underserved communities in healthcare and education.

Education

Project Prosper

Undisclosed

Provides scholarships to meritorious students from low-income families in rural areas.

Business Philosophy & Leadership

Notable Quotes

""Serving Life.""

Leadership Principles

Focus on Affordability

Ensure medicines are accessible to the masses by focusing on low-cost generics.

Brand Building

Create strong brand recognition through consumer-focused advertising.

Strategic Expansion

Drive growth through strategic acquisitions and diversification of product offerings.